Noshiro O, Hirayama R, Shimaya A, Yoneta T, Niigata K, Shikama H
Pharmacology Laboratories, Yamanouchi Pharmaceutical Co., Ltd. Ibaraki, Japan.
Int J Obes Relat Metab Disord. 1997 Feb;21(2):115-21. doi: 10.1038/sj.ijo.0800375.
To determine the role of plasma insulin concentration in regulating glucose and lipid metabolism in insulin-resistant obese Zucker rats and to compare obese rats with lean controls with respect to changes in insulin sensitivity.
Animal study of lean and obese rats with or without insulin sensitizer, YM268.
Nine week old male lean (Fa/-) and obese (fa/fa) Zucker rats.
Plasma glucose, insulin, triglyceride (TG), non-esterified fatty acid (NEFA), cholesterol at baseline and after 14 d, the dose of YM268 for exhibiting a 30% decrease in each parameter (ED30).
Insulin, TG, and NEFA concentrations were approximately 2-6 times higher in obese rats. YM268 had no effect on glucose but decreased insulin in lean and obese rats with ED30 of 3.0 and 2.9 mg/kg. YM268 also reduced TG and NEFA in lean and obese rats (ED30 (mg/kg): lean; 4.1 (TG), 5.0 (NEFA), obese; 2.1, 3.0]. A significant correlation of either TG or NEFA level to insulin was established in lean and obese rats.
Plasma TG and NEFA, but not cholesterol concentration, are dependent on plasma insulin in lean and obese Zucker rats, and insulin sensitivity with respect to TG and NEFA metabolism in obese rats may not be different from that in lean rats.
确定血浆胰岛素浓度在调节胰岛素抵抗肥胖型 Zucker 大鼠糖脂代谢中的作用,并比较肥胖大鼠与瘦素对照大鼠在胰岛素敏感性变化方面的差异。
对有或无胰岛素增敏剂 YM268 的瘦素和肥胖大鼠进行动物研究。
9 周龄雄性瘦素(Fa/-)和肥胖(fa/fa)Zucker 大鼠。
基线及 14 天后的血浆葡萄糖、胰岛素、甘油三酯(TG)、非酯化脂肪酸(NEFA)、胆固醇,以及使各参数降低 30%时 YM268 的剂量(ED30)。
肥胖大鼠的胰岛素、TG 和 NEFA 浓度约高 2 - 6 倍。YM268 对葡萄糖无影响,但可降低瘦素和肥胖大鼠的胰岛素水平,其 ED30 分别为 3.0 和 2.9 mg/kg。YM268 还可降低瘦素和肥胖大鼠的 TG 和 NEFA(ED30(mg/kg):瘦素组;TG 为 4.1,NEFA 为 5.0,肥胖组;TG 为 2.1,NEFA 为 3.0)。在瘦素和肥胖大鼠中,TG 或 NEFA 水平与胰岛素之间均建立了显著相关性。
在瘦素和肥胖型 Zucker 大鼠中,血浆 TG 和 NEFA 而非胆固醇浓度依赖于血浆胰岛素,且肥胖大鼠在 TG 和 NEFA 代谢方面的胰岛素敏感性可能与瘦素大鼠无差异。